Apolipoprotein E3-Leiden (APOE*3-Leiden) transgenic mice have been used to study the effect of different cholesterol-containing diets on the remnant lipoprotein levels and composition and on the possible concurrent development of atherosclerotic plaques. On high fat/cholesterol (HFC) diet, the high expressing lines 2 and 181 developed severe hypercholesterolemia (up to 40 and 60 mmol/liter, respectively), whereas triglyceride levels remained almost normal when compared with regular mouse diet. The addition of cholate increased the hypercholesterolemic effect of this diet. In lines 2 and 181, serum levels of apo E3-Leiden also increased dramatically upon cholesterol feeding (up to 107 and 300 mg/dl, respectively). In these high expressing APOE*3-Leiden transgenic mice, the increase in both serum cholesterol and apo E3-Leiden occurred mainly in the VLDL/LDL-sized fractions, whereas a considerable increase in large, apo E-rich HDL particles also occurred. In contrast to the high expressing lines, the low expressing line 195 reacted only mildly upon HFC diet. On HFC diets, the high expresser APOE*3-Leiden mice developed atherosclerotic lesions in the aortic arch, the descending aorta, and the carotid arteries, varying from fatty streaks containing foam cells to severe atherosclerotic plaques containing cholesterol crystals, fibrosis, and necrotic calcified tissue. Quantitative evaluation revealed that the atherogenesis is positively correlated with the serum level of cholesterol-rich VLDL/LDL particles. In conclusion, with APOE*3-Leiden transgenic mice, factors can be studied that influence the metabolism of remnant VLDL and the development of atherosclerosis.
B J van Vlijmen, A M van den Maagdenberg, M J Gijbels, H van der Boom, H HogenEsch, R R Frants, M H Hofker, L M Havekes
Title and authors | Publication | Year |
---|---|---|
Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic mice
Jongejan YK, Dirven RJ, Schrader Echeverri E, de Jong AJ, Pronk AC, Kooijman S, Rensen PC, Dahlman JE, Eikenboom JC, van Vlijmen BJ |
Research and Practice in Thrombosis and Haemostasis | 2025 |
Development of a Microminipig Model of Atherosclerosis for the Evaluation of a HMGCR Inhibitor.
Yamada T, Kawaguchi H, Matsuoka A, Akioka K, Miura N, Izumi H, Tanimoto A |
In vivo (Athens, Greece) | 2024 |
Nanomedicine for Diagnosis and Treatment of Atherosclerosis.
Cheng J, Huang H, Chen Y, Wu R |
2023 | |
Atherosclerosis: Methods and Protocols
D Ramji |
2022 | |
Characterization of Retinal Drusen in Subjects at High Genetic Risk of Developing Sporadic Alzheimer's Disease: An Exploratory Analysis.
López-Cuenca I, Salobrar-García E, Gil-Salgado I, Sánchez-Puebla L, Elvira-Hurtado L, Fernández-Albarral JA, Ramírez-Toraño F, Barabash A, de Frutos-Lucas J, Salazar JJ, Ramírez JM, Ramírez AI, de Hoz R |
Journal of Personalized Medicine | 2022 |
Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans
Ying Z, Tramper N, Zhou E, Boon MR, Rensen PC, Kooijman S |
Cardiovascular Research | 2022 |
Vascular Calcification in Rodent Models—Keeping Track with an Extented Method Assortment
J Herrmann, MR Gummi, M Xia, M van der Giet, M Tölle, M Schuchardt |
Biology : open access journal | 2021 |
P300/CBP Associated Factor (PCAF) Deficiency Enhances Diet-Induced Atherosclerosis in ApoE3*Leiden Mice via Systemic Inhibition of Regulatory T Cells
A de Jong, RC de Jong, EA Peters, R Arens, JW Jukema, MR de Vries, PH Quax |
Frontiers in Cardiovascular Medicine | 2021 |
The effect of cold exposure on serum cholesterol is dependent upon ApoE
F He, W Su, R Wu, H Li, L Lou, A Wu, L Xie, Y Du, S Wu |
Journal of Thermal Biology | 2021 |
Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice
YK Jongejan, JC Eikenboom, MJ Gijbels, JF Berbée, BJ van Vlijmen |
Journal of Thrombosis and Thrombolysis | 2021 |
Research Models for Studying Vascular Calcification
J Herrmann, M Babic, M Tölle, M van der Giet, M Schuchardt |
International journal of molecular sciences | 2020 |
Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models
D Basu, KE Bornfeldt |
Frontiers in Endocrinology | 2020 |
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
P Golforoush, DM Yellon, SM Davidson |
Basic Research in Cardiology | 2020 |
Small rodent models of atherosclerosis
Y Zhao, H Qu, Y Wang, W Xiao, Y Zhang, D Shi |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2020 |
Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury
NJ Pluijmert, MC den Haan, VL van Zuylen, P Steendijk, HC de Boer, AJ van Zonneveld, WE Fibbe, MJ Schalij, PH Quax, DE Atsma, V Lionetti |
PloS one | 2019 |
Effects of Pharmacological Thermogenic Adipocyte Activation on Metabolism and Atherosclerotic Plaque Regression
A Worthmann, C Schlein, J Berbée, P Rensen, J Heeren, A Bartelt |
Nutrients | 2019 |
Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development
E Zhou, G Hoeke, Z Li, AC Eibergen, AW Schonk, M Koehorst, R Boverhof, R Havinga, F Kuipers, T Coskun, MR Boon, AK Groen, PC Rensen, JF Berbée, Y Wang |
Cardiovascular Research | 2019 |
Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease
AD Marais |
Pathology | 2019 |
CKIP-1 limits foam cell formation and inhibits atherosclerosis by promoting degradation of Oct-1 by REGγ
J Fan, L Liu, Q Liu, Y Cui, B Yao, M Zhang, Y Gao, Y Fu, H Dai, J Pan, Y Qiu, CH Liu, F He, Y Wang, L Zhang |
Nature Communications | 2019 |
Local intravascular delivery of low-density-lipoprotein cholesterol corresponds with increased intimal thickening in a healthy porcine coronary model. A prelude to development of a model of atherosclerosis
PP Buszman, B Orlik, KP Milewski, T Roleder, M Jelonek, F Polczyk, FD Kolodgie, M Jankowski, R Virmani, PE Buszman |
POSTEP KARDIOL INTER | 2019 |
The APOE ∗ 3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis
MG Pouwer, SE Heinonen, M Behrendt, AC Andréasson, A van Koppen, AL Menke, EJ Pieterman, AM van den Hoek, JW Jukema, B Leighton, AC Jönsson-Rylander, HM Princen |
Journal of Diabetes Research | 2019 |
Modelling of atherosclerosis in genetically modified animals
Natalia V Mushenkova, Volha I Summerhill, Yulia Yu Silaeva, Alexey V Deykin, Alexander N Orekhov |
American journal of translational research | 2019 |
Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions
Elizabeth D Crane, Ali A. Al-Hashimi, Jack Chen, Edward G. Lynn, Kevin D Won, Šárka Lhotak, Magda Naeim, Khrystyna Platko, Paul Lebeau, Jae Hyun Byun, Bobby Shayegan, Katey Rayner, Joan Krepinsky, Serena Marchiò, Renata Pasqualini, Wadih Arap, Richard C. Austin |
JCI Insight | 2018 |
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr−/− mice
M Bijnen, N Beelen, S Wetzels, J van de Gaar, M Vroomen, E Wijnands, JL Scheijen, MP van de Waarenburg, MJ Gijbels, JP Cleutjens, EA Biessen, CD Stehouwer, CG Schalkwijk, K Wouters |
Scientific Reports | 2018 |
Understanding the Impact of Dietary Cholesterol on Chronic Metabolic Diseases through Studies in Rodent Models
Á Vinué, A Herrero-Cervera, H González-Navarro |
Nutrients | 2018 |
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects
M Lupo, N Ferri |
Journal of Cardiovascular Development and Disease | 2018 |
Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis
Y Luo, H Duan, Y Qian, L Feng, Z Wu, F Wang, J Feng, D Yang, Z Qin, X Yan |
Cell Research | 2017 |
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
FE Dewey, V Gusarova, RL Dunbar, C ODushlaine, C Schurmann, O Gottesman, S McCarthy, CV Hout, S Bruse, HM Dansky, JB Leader, MF Murray, MD Ritchie, HL Kirchner, L Habegger, A Lopez, J Penn, A Zhao, W Shao, N Stahl, AJ Murphy, S Hamon, A Bouzelmat, R Zhang, B Shumel, R Pordy, D Gipe, GA Herman, WH Sheu, IT Lee, KW Liang, X Guo, JI Rotter, YD Chen, WE Kraus, SH Shah, S Damrauer, A Small, DJ Rader, AB Wulff, BG Nordestgaard, A Tybjærg-Hansen, AM van den Hoek, HM Princen, DH Ledbetter, DJ Carey, JD Overton, JG Reid, WJ Sasiela, P Banerjee, AR Shuldiner, IB Borecki, TM Teslovich, GD Yancopoulos, SJ Mellis, J Gromada, A Baras |
New England Journal of Medicine | 2017 |
The P2Y 2 nucleotide receptor is an inhibitor of vascular calcification
S Qian, JN Regan, MT Shelton, A Hoggatt, KS Mohammad, PB Herring, CI Seye |
Atherosclerosis | 2017 |
Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development
PP Khedoe, S Kleijn, AM van Oeveren-Rietdijk, JJ Plomp, HC de Boer, M Pel, PC Rensen, JF Berbée, PS Hiemstra, AÖ Yildirim |
PloS one | 2017 |
Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease
GH Norris, CN Blesso |
Nutrition Reviews | 2017 |
Experimental Models of Hyperlipoproteinemia and Atherosclerosis
R Poledne, L Jurčíková-Novotná |
Physiological research / Academia Scientiarum Bohemoslovaca | 2017 |
Translational atherosclerosis research: From experimental models to coronary artery disease in humans
CA Gleissner |
Atherosclerosis | 2016 |
Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation
S Qian, A Hoggatt, YL Jones-Hall, CF Ware, P Herring, CI Seye |
Vascular Pharmacology | 2016 |
Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
S Gargiulo, M Gramanzini, M Mancini |
International journal of molecular sciences | 2016 |
Endothelial Jag1-RBPJ signalling promotes inflammatory leucocyte recruitment and atherosclerosis
M Nus, B Martínez-Poveda, D MacGrogan, R Chevre, GD Amato, M Sbroggio, C Rodríguez, J Martínez-González, V Andrés, A Hidalgo, JL de la Pompa |
Cardiovascular Research | 2016 |
Early intake of long-chain polyunsaturated fatty acids preserves brain structure and function in diet-induced obesity
IA Arnoldussen, V Zerbi, M Wiesmann, RH Noordman, S Bolijn, MP Mutsaers, PJ Dederen, R Kleemann, T Kooistra, EA van Tol, G Gross, MH Schoemaker, A Heerschap, PY Wielinga, AJ Kiliaan |
The Journal of Nutritional Biochemistry | 2016 |
Employing biomarkers of healthy ageing for leveraging genetic studies into human longevity
J Deelen, EB van Akker, S Trompet, D Heemst, SP Mooijaart, PE Slagboom, M Beekman |
Experimental Gerontology | 2016 |
L’attivazione del grasso bruno riduce l’ipercolesterolemia e protegge dallo sviluppo dell’aterosclerosi
A Fabbri |
L'Endocrinologo | 2016 |
Classification for Longevity Potential: The Use of Novel Biomarkers
M Beekman, HW Uh, D Heemst, M Wuhrer, LR Ruhaak, V Gonzalez-Covarrubias, T Hankemeier, JJ Houwing-Duistermaat, PE Slagboom |
Frontiers in public health | 2016 |
Deletion of P2Y 2 receptor reveals a role for lymphotoxin-α in fatty streak formation
S Qian, A Hoggatt, YL Jones-Hall, CF Ware, P Herring, CI Seye |
Vascular Pharmacology | 2016 |
Insulin decreases atherosclerotic plaque burden and increases plaque stability via nitric oxide synthase in apolipoprotein E-null mice
Y Mori, S Chiang, MP Bendeck, A Giacca |
American journal of physiology. Endocrinology and metabolism | 2016 |
Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease
PP Khedoe, PC Rensen, JF Berbée, PS Hiemstra |
American journal of physiology. Lung cellular and molecular physiology | 2016 |
Methods in Molecular Biology
GS Getz, CA Reardon |
Methods in molecular biology (Clifton, N.J.) | 2015 |
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
JF Berbée, MR Boon, PP Khedoe, A Bartelt, C Schlein, A Worthmann, S Kooijman, G Hoeke, IM Mol, C John, C Jung, N Vazirpanah, LP Brouwers, PL Gordts, JD Esko, PS Hiemstra, LM Havekes, L Scheja, J Heeren, PC Rensen |
Nature Communications | 2015 |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
S Kuhnast, JW van der Hoorn, EJ Pieterman, AM van Hoek, WJ Sasiela, V Gusarova, A Peyman, HL Schafer, U Schwahn, JW Jukema, HM Princen |
Journal of lipid research | 2014 |
Most appropriate animal models to study the efficacy of statins: a systematic review
V Pecoraro, L Moja, L Dall'Olmo, G Cappellini, S Garattini |
European Journal of Clinical Investigation | 2014 |
New prospect of bile acid sequestrants as a novel therapy for metabolic disorders — research strategy utilizing clinical data
K Sugimoto |
Folia Pharmacologica Japonica | 2014 |
Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation
R Mukhopadhyay |
Journal of Applied Genetics | 2013 |
Animal Models for the Study of Human Disease
HA Lawson |
Animal Models for the Study of Human Disease | 2013 |
Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion
K Sugimoto-Kawabata, H Shimada, K Sakai, K Suzuki, T Kelder, EJ Pieterman, LH Cohen, LM Havekes, HM Princen, AM van Hoek |
Journal of lipid research | 2013 |
Modelos experimentales de aterosclerosis
CG Santos-Gallego, JJ Badimon, B Ibáñez |
Revista Española de Cardiología Suplementos | 2013 |
The Effect of PPE-Induced Emphysema and Chronic LPS-Induced Pulmonary Inflammation on Atherosclerosis Development in APOE*3-LEIDEN Mice
PP Khedoe, MC Wong, GT Wagenaar, JJ Plomp, M Eck, LM Havekes, PC Rensen, PS Hiemstra, JF Berbée, C Taube |
PloS one | 2013 |
Combined Analysis of Pharmacokinetic and Efficacy Data of Preclinical Studies with Statins Markedly Improves Translation of Drug Efficacy to Human Trials
E van de Steeg, R Kleemann, HT Jansen, W van Duyvenvoorde, EH Offerman, HM Wortelboer, J DeGroot |
The Journal of pharmacology and experimental therapeutics | 2013 |
Chronic Intermittent Hypoxia Is an Independent Causative Factor For Atherosclerosis In The Mice
Guoqiang Fang, Dongmei Song, Xiaobing Ye, Sun-zhong Mao, Gang Liu, Shu Fang Liu |
Biochimica et Biophysica Acta | 2012 |
Animal Models of Atherosclerosis
GS Getz, CA Reardon |
Arteriosclerosis, thrombosis, and vascular biology | 2012 |
GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice
ET Parlevliet, Y Wang, JJ Geerling, JP der Elst, K Picha, K O'Neil, V Stojanovic-Susulic, T Ort, LM Havekes, JA Romijn, H Pijl, PC Rensen |
PloS one | 2012 |
Current Protocols in Immunology
E Maganto-Garcia, M Tarrio, AH Lichtman |
Current Protocols in Immunology | 2012 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Dietary modification of metabolic pathways via nuclear hormone receptors: NUCLEAR HORMONE RECEPTORS AND NUTRITION
G Caiozzi, BS Wong, ML Ricketts |
Cell Biochemistry and Function | 2012 |
Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet
A Oksaharju, T Kooistra, R Kleemann, W Duyvenvoorde, M Miettinen, J Lappalainen, KA Lindstedt, PT Kovanen, R Korpela, RA Kekkonen |
British Journal of Nutrition | 2012 |
Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50
G Fang, D Song, X Ye, S Mao, G Liu, SF Liu |
The American Journal of Pathology | 2012 |
GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
ET Parlevliet, Y Wang, JJ Geerling, JP der Elst, K Picha, K O'Neil, V Stojanovic-Susulic, T Ort, LM Havekes, JA Romijn, H Pijl, PC Rensen, E Lutgens |
PloS one | 2012 |
Identification of prognostic and diagnostic biomarkers of glucose intolerance in ApoE3Leiden mice
S Wopereis, M Radonjic, C Rubingh, M Erk, A Smilde, W Duyvenvoorde, N Cnubben, T Kooistra, B Ommen, R Kleemann |
Physiological genomics | 2012 |
Lipidomics Reveals Multiple Pathway Effects of a Multi-Components Preparation on Lipid Biochemistry in ApoE*3Leiden.CETP Mice
H Wei, C Hu, M Wang, AM van Hoek, TH Reijmers, S Wopereis, J Bouwman, R Ramaker, HA Korthout, M Vennik, T Hankemeier, LM Havekes, RF Witkamp, ER Verheij, G Xu, J der Greef, M Federici |
PloS one | 2012 |
Effect of 9p21.3 Coronary Artery Disease Locus Neighboring Genes on Atherosclerosis in Mice
JB Kim, A Deluna, IN Mungrue, C Vu, D Pouldar, M Civelek, L Orozco, J Wu, X Wang, S Charugundla, LW Castellani, M Rusek, H Jakubowski, AJ Lusis |
Circulation | 2012 |
Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels
J der Hoorn, D Lindén, U Lindahl, M Bekkers, M Voskuilen, R Nilsson, J Oscarsson, E Lindstedt, H Princen |
British Journal of Pharmacology | 2011 |
Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice
C Hu, H Wei, AM van Hoek, M Wang, R der Heijden, G Spijksma, TH Reijmers, J Bouwman, S Wopereis, LM Havekes, E Verheij, T Hankemeier, G Xu, J der Greef |
PloS one | 2011 |
Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited
J Deelen, M Beekman, HW Uh, Q Helmer, M Kuningas, L Christiansen, D Kremer, R der Breggen, HE Suchiman, N Lakenberg, EB van Akker, WM Passtoors, H Tiemeier, D Heemst, AJ de Craen, F Rivadeneira, EJ de Geus, M Perola, FJ van der Ouderaa, DA Gunn, DI Boomsma, AG Uitterlinden, K Christensen, CM van Duijn, BT Heijmans, JJ Houwing-Duistermaat, RG Westendorp, PE Slagboom |
Aging Cell | 2011 |
Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients
FI Staquicini, M Cardó-Vila, MG Kolonin, M Trepel, JK Edwards, DN Nunes, A Sergeeva, E Efstathiou, J Sun, NF Almeida, SM Tu, GH Botz, MJ Wallace, DJ O'Connell, S Krajewski, JE Gershenwald, JJ Molldrem, AL Flamm, E Koivunen, RD Pentz, E Dias-Neto, JC Setubal, DJ Cahill, P Troncoso, KA Do, CJ Logothetis, RL Sidman, R Pasqualini, W Arap |
Proceedings of the National Academy of Sciences | 2011 |
Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice
C Hu, H Wei, AM van Hoek, M Wang, R der Heijden, G Spijksma, TH Reijmers, J Bouwman, S Wopereis, LM Havekes, E Verheij, T Hankemeier, G Xu, J der Greef, M Oresic |
PloS one | 2011 |
Microminipig, a Non-rodent Experimental Animal Optimized for Life Science Research: Novel Atherosclerosis Model Induced by High Fat and Cholesterol Diet
H Kawaguchi, N Miyoshi, N Miura, M Fujiki, M Horiuchi, Y Izumi, H Miyajima, R Nagata, K Misumi, T Takeuchi, A Tanimoto, H Yoshida |
Journal of Pharmacological Sciences | 2011 |
Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice
MC Meuwese, LN Broekhuizen, M Kuikhoven, S Heeneman, E Lutgens, MJ Gijbels, M Nieuwdorp, CJ Peutz, ES Stroes, H Vink, BM van Berg |
PloS one | 2010 |
Ritonavir protects against the development of atherosclerosis in APOE*3-Leiden mice
MA Boer, M Westerterp, JV der Weij, Y Wang, L Hu, SM Santo, T Kooistra, P Reiss, JA Romijn, LM Havekes, PC Rensen |
Atherosclerosis | 2010 |
In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor
D Eefting, MR de Vries, JM Grimbergen, JC Karper, JH van Bockel, PH Quax |
Journal of Vascular Surgery | 2010 |
A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease
D Eefting, L Seghers, JM Grimbergen, MR de Vries, HC de Boer, JW Lardenoye, JW Jukema, JH van Bockel, PH Quax |
Cardiovascular Research | 2010 |
Endothelial Surface Layer Degradation by Chronic Hyaluronidase Infusion Induces Proteinuria in Apolipoprotein E-Deficient Mice
MC Meuwese, LN Broekhuizen, M Kuikhoven, S Heeneman, E Lutgens, MJ Gijbels, M Nieuwdorp, CJ Peutz, ES Stroes, H Vink, BM van Berg, HH Schmidt |
PloS one | 2010 |
Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall
AJ Guri, SA Misyak, R Hontecillas, A Hasty, D Liu, H Si, J Bassaganya-Riera |
The Journal of Nutritional Biochemistry | 2010 |
Lipid metabolism in long-lived families: the Leiden Longevity Study.
Vaarhorst AA, Beekman M, Suchiman EH, van Heemst D, Houwing-Duistermaat JJ, Westendorp RG, Slagboom PE, Heijmans BT |
Age (Dordrecht, Netherlands) | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Pharmacotherapy of coronary atherosclerosis
AV Finn, MC Kramer, M Vorpahl, FD Kolodgie, R Virmani |
Expert Opinion on Pharmacotherapy | 2009 |
The dual PPARα/γ agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice
JW van der Hoorn, JW Jukema, LM Havekes, E Lundholm, G Camejo, PC Rensen, HM Princen |
British Journal of Pharmacology | 2009 |
Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program
M Radonjic, JR de Haan, MJ van Erk, KW van Dijk, SA van Berg, PJ de Groot, M Müller, B Ommen |
PloS one | 2009 |
Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease
SM Bailey, SK Mantena, T Millender-Swain, Y Cakir, NC Jhala, D Chhieng, KE Pinkerton, SW Ballinger |
Free radical biology & medicine | 2009 |
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice
D Eefting, I Bot, MR de Vries, A Schepers, JH van Bockel, TJ van Berkel, EA Biessen, PH Quax |
Journal of Vascular Surgery | 2009 |
Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol
S Andrade, N Borges |
Journal of Dairy Research | 2009 |
Genome-Wide mRNA Expression Analysis of Hepatic Adaptation to High-Fat Diets Reveals Switch from an Inflammatory to Steatotic Transcriptional Program
M Radonjic, JR de Haan, MJ van Erk, KW van Dijk, SA van Berg, PJ de Groot, M Müller, B Ommen, TI Sorensen |
PloS one | 2009 |
Animal and cellular models for hypolipidemic drugs
A Cignarella |
Expert Opinion on Drug Discovery | 2008 |
Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice
BM Berg, JA Spaan, H Vink |
Pflügers Archiv - European Journal of Physiology | 2008 |
Endothelial Cell-Specific NF-κB Inhibition Protects Mice from Atherosclerosis
R Gareus, E Kotsaki, S Xanthoulea, I der Made, MJ Gijbels, R Kardakaris, A Polykratis, G Kollias, MP de Winther, M Pasparakis |
Cell Metabolism | 2008 |
Dietary fatty acids affecting hepatic metabolism and atherosclerosis – mechanisms unravelled using a proteomics approach
GR Gutiérrez, BD Roos |
Grasas y Aceites | 2008 |
Pathway Analysis for Drug Discovery
A Bugrim, Z Dezso, Y Nikolsky, T Nikolskaya |
Pathway Analysis for Drug Discovery | 2008 |
Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE*3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban)
JW van der Hoorn, JW Jukema, ME Bekkers, HM Princen, S Corda, JJ Emeis, P Steendijk |
Critical Care Medicine | 2008 |
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
W Haan, CC van der Hoogt, M Westerterp, M Hoekstra, GM Dallinga-Thie, HM Princen, JA Romijn, JW Jukema, LM Havekes, PC Rensen |
Atherosclerosis | 2008 |
Genomics: Fundamentals and Applications
S Jackson, I Patel, J LeClerc, T Cebula, M Mammel, M Kotewicz, A Mukherjee, S Mahata, JR Flores, M Mahata, D O’Connor, J Srinivasan |
Genomics: Fundamentals and Applications | 2008 |
Bradykinin- and sodium nitroprusside-induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties: Modulation of capillary glycocalyx exclusion by vasodilators
JW VanTeeffelen, AA Constantinescu, J Brands, JA Spaan, H Vink |
The Journal of Physiology | 2008 |
Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice
BM van den Berg, JA Spaan, H Vink |
Pflügers Archiv - European Journal of Physiology | 2008 |
Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis
R Kleemann, L Verschuren, MJ van Erk, Y Nikolsky, NH Cnubben, ER Verheij, AK Smilde, HF Hendriks, S Zadelaar, GJ Smith, V Kaznacheev, T Nikolskaya, A Melnikov, E Hurt-Camejo, J der Greef, B Ommen, T Kooistra |
Genome biology | 2007 |
Does coffee raise cholesterol?
ML Ricketts |
Future Lipidology | 2007 |
Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice
JW van der Hoorn, R Kleemann, LM Havekes, T Kooistra, HM Princen, JW Jukema |
Journal of Hypertension | 2007 |
Liver X Receptor Alpha Associates With Human Life Span
SP Mooijaart, M Kuningas, RG Westendorp, JJ Houwing-Duistermaat, PE Slagboom, PC Rensen, D Heemst |
The Journals of Gerontology Series A Biological Sciences and Medical Sciences | 2007 |
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
CC van der Hoogt, W Haan, M Westerterp, M Hoekstra, GM Dallinga-Thie, JA Romijn, HM Princen, JW Jukema, LM Havekes, PC Rensen |
Journal of lipid research | 2007 |
ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
SP Mooijaart, JF Berbée, D Heemst, LM Havekes, AJ de Craen, PE Slagboom, PC Rensen, RG Westendorp |
PLoS Medicine | 2006 |
Increased atherosclerotic lesion area in apoE deficient mice overexpressing bovine growth hormone
IJ Andersson, A Ljungberg, L Svensson, LM Gan, J Oscarsson, G Bergström |
Atherosclerosis | 2006 |
Anti-Atherosclerotic Effect of Amlodipine, Alone and in Combination With Atorvastatin, in APOE*3-Leiden/hCRP Transgenic Mice
A Trion, M Maat, W Jukema, A Maas, E Offerman, L Havekes, A Szalai, A der Laarse, H Princen, J Emeis |
Journal of Cardiovascular Pharmacology | 2006 |
Vascular Medicine
ES Klings, J Loscalzo |
Vascular Medicine | 2006 |
The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice
D Eefting, A Schepers, MR de Vries, NM Pires, JM Grimbergen, T Lagerweij, LM Nagelkerken, PS Monraats, JW Jukema, JH van Bockel, PH Quax |
Atherosclerosis | 2006 |
Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols
J Plat, I Beugels, MJ Gijbels, MP de Winther, RP Mensink |
Journal of lipid research | 2006 |
Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice
I Duivenvoorden, PJ Voshol, PC Rensen, W van Duyvenvoorde, JA Romijn, JJ Emeis, LM Havekes, WF Nieuwenhuizen |
The American journal of clinical nutrition | 2006 |
Loss of scavenger receptor mediated lipid uptake via SR-A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
Kathryn J. Moore, Vidya V. Kunjathoor, Stephanie L. Koehn, Jennifer J. Manning, Anita A. Tseng, Jessica M. Silver, Mary McKee and Mason W. Freeman |
Journal of Clinical Investigation | 2005 |
Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice
J Liu, DP Thewke, YR Su, MR Linton, S Fazio, MS Sinensky |
Arteriosclerosis, thrombosis, and vascular biology | 2005 |
Understanding hyperlipidemia and atherosclerosis: lessons from genetically modifiedapoeandldlrmice
K Wouters, R Shiri-Sverdlov, PJ van Gorp, M Bilsen, MH Hofker |
Clinical Chemistry and Laboratory Medicine | 2005 |
Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regulation of lipid and inflammatory genes
AJ Kreeft, CJ Moen, G Porter, S Kasanmoentalib, R Sverdlov, PJ van Gorp, LM Havekes, RR Frants, MH Hofker |
Atherosclerosis | 2005 |
Rosuvastatin Reduces Plasma Lipids by Inhibiting VLDL Production and Enhancing Hepatobiliary Lipid Excretion in ApoE*3-Leiden Mice
DJ Delsing, SM Post, M Groenendijk, K Solaas, H der Boom, W Duyvenvoorde, EC de Wit, VW Bloks, F Kuipers, LM Havekes, HM Princen |
Journal of Cardiovascular Pharmacology | 2005 |
Acute inhibition of hepatic β-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity
I Duivenvoorden, B Teusink, PC Rensen, F Kuipers, JA Romijn, LM Havekes, PJ Voshol |
Journal of lipid research | 2005 |
Hypercholesterolemia impairs reactive hyperemic vasodilation of 2A but not 3A arterioles in mouse cremaster muscle
JW VanTeeffelen, AA Constantinescu, H Vink, JA Spaan |
American journal of physiology. Heart and circulatory physiology | 2005 |
LDL receptor cooperates with LDL receptor–related protein in regulating plasma levels of coagulation factor VIII in vivo
N Bovenschen, K Mertens, L Hu, LM Havekes, BJ van Vlijmen |
Blood | 2005 |
Response of apolipoprotein E*3‐Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data
B de Roos, I Duivenvoorden, G Rucklidge, M Reid, K Ross, RJ Lamers, PJ Voshol, LM Havekes, B Teusink |
The FASEB Journal | 2005 |
Hepatic low-density lipoprotein receptor–related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
SM Santo, NM Pires, LS Boesten, G Gerritsen, N Bovenschen, KW van Dijk, JW Jukema, HM Princen, A Bensadoun, WP Li, J Herz, LM Havekes, BJ van Vlijmen |
Blood | 2004 |
Phenotype Characterisation Using Integrated Gene Transcript, Protein and Metabolite Profiling
M Ore??i??, CB Clish, EJ Davidov, E Verheij, J Vogels, LM Havekes, E Neumann, A Adourian, S Naylor, J der Greef, T Plasterer |
Applied Bioinformatics | 2004 |
Methods for the Differential Integrative Omic Analysis of Plasma from a Transgenic Disease Animal Model
E Davidov, CB Clish, M Oresic, M Meys, W Stochaj, P Snell, G Lavine, TR Londo, A Adourian, X Zhang, M Johnston, N Morel, EW Marple, TN Plasterer, E Neumann, E Verheij, JT Vogels, LM Havekes, JV der Greef, S Naylor |
OMICS: A Journal of Integrative Biology | 2004 |
A practical approach to using mice in atherosclerosis research
SC Whitman |
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists | 2004 |
Absence of an atheroprotective effect of the garlic powder printanor in APOE*3-Leiden transgenic mice
SM Santo, BJ van Vlijmen, W Duyvenvoorde, EH Offerman, LM Havekes, I Arnault, J Auger, HM Princen |
Atherosclerosis | 2004 |
Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158→Cys), and E3-Leiden
SJ Lee, I Grosskopf, SY Choi, AD Cooper |
Journal of lipid research | 2004 |
Well-Characterized Garlic-Derived Materials Are Not Hypolipidemic in APOE*3-Leiden Transgenic Mice
SM Santo, BJ van Vlijmen, R Buytenhek, W van Duyvenvoorde, LM Havekes, I Arnault, J Auger, HM Princen |
The Journal of nutrition | 2004 |
Inhibition of NF-kappaB activation in macrophages promotes atherosclerosis in low-density lipoprotein receptor deficient mice
Edwin Kanters, Manolis Pasparakis, Marion J.J. Gijbels, Monique N. Vergouwe, Iris Partouns-Hendriks, Remond J.A. Fijneman, Björn E. Clausen, Irmgard Förster, Mark M. Kockx, Klaus Rajewsky, Georg Kraal, Marten H. Hofker, Menno P.J. de Winther |
Journal of Clinical Investigation | 2003 |
Differential Effects of Amlodipine and Atorvastatin Treatment and Their Combination on Atherosclerosis in ApoE*3-Leiden Transgenic Mice
DJ Delsing, WJ Jukema, MA van de Wiel, JJ Emeis, A der Laarse, LM Havekes, HM Princen |
Journal of Cardiovascular Pharmacology | 2003 |
Lung Biology in Health and Disease
N Zamel |
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential | 2003 |
Evaluation of antiatherosclerotic drugs by Raman spectroscopy
SW de Poll, A der Laarse |
Netherlands Heart Journal | 2003 |
A Fish Oil Diet Does Not Reverse Insulin Resistance despite Decreased Adipose Tissue TNF-α Protein Concentration in ApoE-3*Leiden Mice
M Muurling, RP Mensink, H Pijl, JA Romijn, LM Havekes, PJ Voshol |
The Journal of nutrition | 2003 |
Cardiac Ankyrin Repeat Protein (CARP) Expression in Human and Murine Atherosclerotic Lesions: Activin Induces Carp in Smooth Muscle Cells
V de Waard, TA van Achterberg, NJ Beauchamp, H Pannekoek, CJ de Vries |
Arteriosclerosis, thrombosis, and vascular biology | 2003 |
Mouse Models of Atherosclerosis
A Daugherty |
The American Journal of the Medical Sciences | 2002 |
Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice
SW van de Poll, DJ Delsing, JW Jukema, HM Princen, LM Havekes, GJ Puppels, A der Laarse |
Atherosclerosis | 2002 |
Generation and Characterization of Two Transgenic Mouse Lines Expressing Human ApoE2 in Neurons and Glial Cells
S Georgopoulos, A McKee, HY Kan, VI Zannis |
Biochemistry | 2002 |
Evaluation of the Role of Lipoprotein Metabolism Genes in Systemic Cationic Liposome-Mediated Gene TransferIn Vivo
LC Mounkes, W Zhong, HV de Silva, C Handumrongkul, B Desai, E Tse, JM Taylor, RJ Debs |
Human Gene Therapy | 2001 |
Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE3-Leiden transgenic mice
OL Volger, RP Mensink, J Plat, G Hornstra, LM Havekes, HM Princen |
Atherosclerosis | 2001 |
Dietary Plant Stanol Esters Reduce VLDL Cholesterol Secretion and Bile Saturation in Apolipoprotein E*3-Leiden Transgenic Mice
OL Volger, H van der Boom, EC de Wit, W van Duyvenvoorde, G Hornstra, J Plat, LM Havekes, RP Mensink, HM Princen |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Mice Expressing Only the Mutant APOE3Leiden Gene Show Impaired VLDL Secretion
AR Mensenkamp, B Teusink, JF Baller, H Wolters, R Havinga, KW van Dijk, LM Havekes, F Kuipers |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Acyl-CoA:Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to Its Cholesterol-Lowering Effect in ApoE*3-Leiden Mice
DJ Delsing, EH Offerman, W van Duyvenvoorde, H van der Boom, EC de Wit, MJ Gijbels, A van der Laarse, JW Jukema, LM Havekes, HM Princen |
Circulation | 2001 |
Compensatory Enlargement and Stenosis Develop in ApoE −/− and ApoE*3-Leiden Transgenic Mice
E Lutgens, ED de Muinck, S Heeneman, MJ Daemen |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice
BJ van Vlijmen, G Gerritsen, AL Franken, LS Boesten, MM Kockx, MJ Gijbels, MP Vierboom, M van Eck, B van de Water, TJ van Berkel, LM Havekes |
Circulation research | 2001 |
Analysis of the structure and function relationship of human apolipoprotein E in vivo, using adenovirus‐mediated gene transfer
KE Kypreos, B Teusink, KO Dijk, LM Havekes, VI Zannis |
The FASEB Journal | 2001 |
APOLIPOPROTEINE: Far More Than a Lipid Transport Protein
RW Mahley, SC Rall |
Annual Review of Genomics and Human Genetics | 2000 |
The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit
M Kliffen, E Lutgens, MJ Daemen, ED de Muinck, CM Mooy, PT de Jong |
The British journal of ophthalmology | 2000 |
Phenotyping apolipoprotein E*3-Leiden transgenic mice by two-dimensional polyacrylamide gel electrophoresis and mass spectrometric identification
JM Skehel, K Schneider, N Murphy, A Graham, GM Benson, P Cutler, P Camilleri |
Electrophoresis | 2000 |
A POLIPOPROTEIN E: Far More Than a Lipid Transport Protein
RW Mahley, SC Rall |
Annual Review of Genomics and Human Genetics | 2000 |
Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis
MP de Winther, KW van Dijk, LM Havekes, MH Hofker |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice
A R Mensenkamp, M J van Luyn, H van Goor, V Bloks, F Apostel, J Greeve, M H Hofker, M C Jong, B J van Vlijmen, L M Havekes, F Kuipers |
Journal of Hepatology | 2000 |
Effect of Macrophage-Derived Mouse ApoE, Human ApoE3-Leiden, and Human ApoE2 (Arg158→Cys) on Cholesterol Levels and Atherosclerosis in ApoE-Deficient Mice
MV Eck, N Herijgers, KW Dijk, LM Havekes, MH Hofker, PH Groot, TJ Berkel |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Accelerated Atherosclerosis by Placement of a Perivascular Cuff and a Cholesterol-Rich Diet in ApoE*3Leiden Transgenic Mice
JH Lardenoye, DJ Delsing, MR de Vries, MM Deckers, HM Princen, LM Havekes, VW van Hinsbergh, JH van Bockel, PH Quax |
Circulation research | 2000 |
Cafestol Increases Serum Cholesterol Levels in Apolipoprotein E*3-Leiden Transgenic Mice by Suppression of Bile Acid Synthesis
SM Post, B de Roos, M Vermeulen, L Afman, MC Jong, VE Dahlmans, LM Havekes, F Stellaard, MB Katan, HM Princen |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Apolipoprotein E and atherosclerosis: insight from animal and human studies
J Davignon, JS Cohn, L Mabile, L Bernier |
Clinica Chimica Acta | 1999 |
Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice
MP de Winther, MJ Gijbels, KW van Dijk, PJ van Gorp, H Suzuki, T Kodama, RR Frants, LM Havekes, MH Hofker |
Atherosclerosis | 1999 |
Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study
MJ Gijbels, M der Cammen, LJ van der Laan, JJ Emeis, LM Havekes, MH Hofker, G Kraal |
Atherosclerosis | 1999 |
Acyl-coenzyme A: Cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7?-hydroxylase in cultured rat hepatocytes andin vivo in the rat
SM Post, JP Zoeteweij, MH Bos, EC de Wit, R Havinga, F Kuipers, HM Princen |
Hepatology | 1999 |
Atherosclerosis in APOE*3-Leiden Transgenic Mice: From Proliferative to Atheromatous Stage
E Lutgens, M Daemen, M Kockx, P Doevendans, M Hofker, L Havekes, H Wellens, ED de Muinck |
Circulation | 1999 |
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes
RW Mahley, Y Huang, SC Rall |
Journal of lipid research | 1999 |
Dissection of the complex role of apolipoprotein E in lipoprotein metabolism and atherosclerosis using mouse models
KW van Dijk, MH Hofker, LM Havekes |
Current Atherosclerosis Reports | 1999 |
Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis
MH Hofker, BJ van Vlijmen, LM Havekes |
Atherosclerosis | 1998 |
LIPOPROTEINS AND ATHEROGENESIS
JM Hoeg |
Endocrinology & Metabolism Clinics of North America | 1998 |
Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice
P Leppänen, JS Luoma, MH Hofker, LM Havekes, S Ylä-Herttuala |
Atherosclerosis | 1998 |
Trends in Molecular Medicine: Molecular determinants of arterial calcification
T Schinke, MD McKee, R Kiviranta, G Karsenty |
Annals of Medicine | 1998 |
Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?
BR Krause, HM Princen |
Atherosclerosis | 1998 |
Dietary cholesterol-induced xanthomatosis in atherosclerosis-susceptible Japanese quail (Cotunix japonica)
KA Hoekstra, CR Nichols, ME Garnett, DV Godin, KM Cheng |
Journal of Comparative Pathology | 1998 |
Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice
BJ van Vlijmen, RP Mensink, , RF Offermans, MH Hofker, LM Havekes |
Journal of lipid research | 1998 |
Atherosclerosis and the Mouse: A Decade of Experience
A Plump |
Annals of Medicine | 1997 |
Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner
MC Jong, VE Dahlmans, MH Hofker, LM Havekes |
Biochemical Journal | 1997 |
Use of transgenic mice in lipoprotein metabolism and atherosclerosis research
LM Havekes, BJ Vlijmen, MC Jong, KW Dijk, MH Hofker |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1997 |
Apolipoprotein E2 Transgenic Rabbits: MODULATION OF THE TYPE III HYPERLIPOPROTEINEMIC PHENOTYPE BY ESTROGEN AND OCCURRENCE OF SPONTANEOUS ATHEROSCLEROSIS
Y Huang, SW Schwendner, SC Rall, DA Sanan, RW Mahley |
The Journal of biological chemistry | 1997 |
Diagnostics of Vascular Diseases
P Lanzer, M Lipton |
1997 | |
Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice
BJ van Vlijmen, HB van Hof, MJ Mol, H der Boom, A der Zee, RR Frants, MH Hofker, LM Havekes |
Journal of Clinical Investigation | 1996 |
In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway
MC Jong, VE Dahlmans, PJ van Gorp, KW van Dijk, ML Breuer, MH Hofker, LM Havekes |
Journal of Clinical Investigation | 1996 |
Triglycerides: a risk factor for coronary heart disease
J Davignon, JS Cohn |
Atherosclerosis | 1996 |
Hypolipidemic and Hyperlipidemic Phenotypes in Transgenic Mice Expressing Human Apolipoprotein E2
Y Huang, SW Schwendner, SC Rall, RW Mahley |
The Journal of biological chemistry | 1996 |
In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E*2(Arg-158 → Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E*3-Leiden Transgenic Mice
BJ van Vlijmen, KW van Dijk, HB Hof, PJ van Gorp, A der Zee, H der Boom, ML Breuer, MH Hofker, LM Havekes |
The Journal of biological chemistry | 1996 |
Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic Subjects
JS Cohn, M Tremblay, M Amiot, D Bouthillier, M Roy, J Genest, J Davignon |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1
MC Jong, VE Dahlmans, PJ van Gorp, ML Breuer, MJ Mol, A van der Zee, RR Frants, MH Hofker, LM Havekes |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Quantitative Assessment of Aortic Atherosclerosis in APOE*3 Leiden Transgenic Mice and Its Relationship to Serum Cholesterol Exposure
PH Groot, BJ van Vlijmen, GM Benson, MH Hofker, R Schiffelers, M Vidgeon-Hart, LM Havekes |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson |
1996 | |
Mouse Models of Atherosclerosis
JL Breslow |
Science | 1996 |
Increased response to cholesterol feeding in apolipoprotein C1-deficient mice
JH van Ree, MH Hofker, WJ van Broek, JM van Deursen, H der Boom, RR Frants, B Wieringa, LM Havekes |
Biochemical Journal | 1995 |
Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding
J Vanree, M Gijbels, W Vandenbroek, M Hofker, L Havekes |
Atherosclerosis | 1995 |
Targeted Inactivation of the Mouse α 2 -Macroglobulin Gene
L Umans, L Serneels, L Overbergh, K Lorent, FV Leuven, HV Berghe |
The Journal of biological chemistry | 1995 |
Relative Contributions of Apolipoprotein(a) and Apolipoprotein-B to the Development of Fatty Lesions in the Proximal Aorta of Mice
FP Mancini, DL Newland, V Mooser, J Murata, S Marcovina, SG Young, RE Hammer, DA Sanan, HH Hobbs |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Cardiovascular Disease 2
LL Gallo |
1995 | |
Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lysl46→Gln) are inefficiently converted to cholesterol-rich lipoproteins
M Mulder, H der Boom, P Kniff, C Braam, A Maagdenberg, JA Leuven, LM Havekes |
Atherosclerosis | 1994 |
Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice
JH van Ree, WJ van Broek, VE Dahlmans, PH Groot, M Vidgeon-Hart, RR Frants, B Wieringa, LM Havekes, MH Hofker |
Atherosclerosis | 1994 |
Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142)
S Fazio, DA Sanan, YL Lee, ZS Ji, RW Mahley, SC Rall |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Animal models of atherosclerosis
ML Armstrong, DD Heistad |
Atherosclerosis | 1990 |